DEEP SEQUENCING ANALYSES IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN THE COSMOS STUDY

被引：0
|
作者：
Fevery, B. [1 ]
Thys, K. [1 ]
Van Rossem, E. [1 ]
Verbinnen, T. [1 ]
Picchio, G. [2 ]
Aerssens, J. [1 ]
De Meyer, S. [1 ]
Beumont, M. [1 ]
Kurland, D. [2 ]
Lenz, O. [1 ]
机构：
[1] Janssen Infect Dis BVBA, Beerse, Belgium
[2] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30983-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0780
引用
收藏
页码：S623 / S623
页数：1
相关论文
共 50 条
  • [31] Efficacy by Race or Geographic Region in HCV Genotype 1-infected Patients Treated with ABT-450/ritonavir/Ombitasvir and Dasabuvir With or Without Ribavirin
    Vierling, John M.
    Puoti, Massimo
    Bernstein, David Eric
    Tsai, Naoky
    Weiland, Ola
    Romero-Gomez, Manuel
    Caruntu, Florin A.
    DuFour, Jean-Francois J.
    Calinas, Filipe
    Larsen, Lois
    Tatsch, Fernando
    Andreone, Pietro
    HEPATOLOGY, 2014, 60 : 1156A - 1157A
  • [32] Integrated Safety Analysis of Daclatasvir Plus Sofosbuvir, With or Without Ribavirin, in Patients With HCV Genotype 3 Infection
    Bernstein, David
    Landis, Charles S.
    Lawitz, Eric
    Luetkemeyer, Anne
    Harris, Melissa
    Bhore, Rafia
    Swenson, Eugene S.
    Ackerman, Peter
    Rana, Khurram
    Dieterich, Douglas
    HEPATOLOGY, 2015, 62 : 571A - 571A
  • [33] Safety and efficacy of Sofosbuvir/Velpatasvir with and without Ribavirin in genotype 3HCV-infected patients with cirrhosis
    Ferret, M. B.
    Pineda, J.
    Panero, J. L. C.
    Rodriguez, M.
    Morillas, R. M.
    Pascasio, J. M.
    Rivero, A.
    Mcnabb, B.
    Zhang, G.
    Camus, G.
    Stamm, L.
    Brainard, D.
    Subramanian, M.
    Carrion, J. A.
    Andrade, R. J.
    Amado, L. E. M.
    Turnes, J.
    Lens, S.
    Casado, M.
    Esteban, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S20 - S21
  • [34] Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis
    Ogawa, Eiichi
    Furusyo, Norihiro
    Nomura, Hideyuki
    Takahashi, Kazuhiro
    Higashi, Nobuhiko
    Kawano, Akira
    Dohmen, Kazufumi
    Satoh, Takeaki
    Azuma, Koichi
    Nakamuta, Makoto
    Koyanagi, Toshimasa.
    Kato, Masaki
    Shimoda, Shinji
    Kajiwara, Eiji
    Hayashi, Jun
    ANTIVIRAL RESEARCH, 2016, 136 : 37 - 44
  • [35] Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study
    Fevery, B.
    Verbinnen, T.
    Peeters, M.
    Janssen, K.
    Witek, J.
    Jessner, W.
    De Meyer, S.
    Lenz, O.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (01) : 28 - 36
  • [36] Sofosbuvir plus Ribavirin for the Treatment of Russian Patients with Chronic HCV Genotype 1 or 3 Infection
    Chulanov, Vladimir
    Zhdanov, Konstantin
    Kersey, Kathryn
    Zhu, Yanni
    Massetto, Benedetta
    Zhuravel, Sergey
    Romanova, Svetlana
    Nurmukhametova, Elena
    Morozov, Viacheslav
    Kozhevnikova, Galina
    Gogova, Larisa
    Geyvandova, Natalia
    Gankina, Natalia
    Chesnokov, Evgenii
    Burnevich, Eduard Z.
    Bessonova, Elena
    Abdurakhmanov, Djamal
    Brainard, Diana M.
    McHutchison, John G.
    Bakulin, Igor G.
    Isakov, Vasily
    HEPATOLOGY, 2014, 60 : 676A - 677A
  • [37] Long-Term Efficacy of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Patients With or Without Cirrhosis
    Zeuzem, Stefan
    Jacobson, Ira M.
    Feld, Jordan J.
    Wedemeyer, Heiner
    Forns, Xavier
    Andreone, Pietro
    Colombo, Massimo
    Bernstein, David
    Poordad, Fred
    Hezode, Christophe
    Podsadecki, Thomas
    Xie, Wangang
    Pilot-Matias, Tami
    Vilchez, Regis A.
    Vierling, John M.
    HEPATOLOGY, 2015, 62 : 743A - 744A
  • [38] SIMEPREVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS: EFFICACY AND SAFETY IN REAL LIFE
    Ramos, H.
    Gomez, J.
    Linares, P.
    Martin, I.
    Almohalla, C.
    Jorquera, F.
    Garcia, I.
    Vasquez, M.
    Conde, P.
    Badia, E.
    Alvarez, B.
    Karpman, G.
    Lorenzo, S.
    Gozalo, V.
    Joao, D.
    de Benito, M.
    Ruiz, L.
    Jimenez, F.
    Saez-Rouela, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S765 - S766
  • [39] Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
    Kanda, Tatsuo
    Nakamura, Masato
    Yasui, Shin
    Haga, Yuki
    Tawada, Akinobu
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Takahashi, Koji
    Sasaki, Reina
    Wu, Shuang
    Nakamoto, Shingo
    Arai, Makoto
    Imazeki, Fumio
    Yokosuka, Osamu
    BIOLOGY-BASEL, 2017, 6 (02):
  • [40] Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
    Aqel, Bashar A.
    Pungpapong, Surakit
    Leise, Michael
    Werner, K. Tuesday
    Chervenak, Amy E.
    Watt, Kymberly D.
    Murphy, Jennifer L.
    Ryland, Kristen
    Keaveny, Andrew P.
    McLemore, Ryan
    Vargas, Hugo E.
    HEPATOLOGY, 2015, 62 (04) : 1004 - 1012
12345